| Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | | 2024 | 89 | 112 |
|
| Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans | Cardiovascular research | | | 2023 | 75 | 78 |
|
| Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein I | Research and practice in thrombosis and haemostasis | | | 2022 | 198 | 626 |
|
| High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD? | 90th European Atherosclerosis Society (EAS) congress | | | 2022 | 165 | 0 |
|
| Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery disease | International journal of molecular sciences | | | 2022 | 199 | 211 |
|
| Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells | Cells | | | 2022 | 227 | 595 |
|
| NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis | International journal of molecular sciences | | | 2021 | 273 | 222 |
|
| Autoantibodies directed against apolipoprotein-A1 as a potential contributor to Non-Alcoholic Fatty Liver Disease | 89th Europen Society of Atherosclerosis (EAS) | | | 2021 | 149 | 0 |
|
| Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet | Cardiovascular Research | | | 2021 | 225 | 206 |
|
| Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques | International Journal of Molecular Sciences | | | 2020 | 246 | 154 |
|
| Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression | Scientific Reports | | | 2020 | 228 | 277 |
|
| Atherosclerotic plaque vulnerability is increased in mouse model of lupus | Scientific Reports | | | 2020 | 330 | 256 |
|
| Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3 | Thrombosis and Haemostasis | | | 2020 | 255 | 0 |
|
| Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population | Clinical & translational immunology | | | 2020 | 211 | 178 |
|
| Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence | Journal of cardiovascular medicine | | | 2020 | 226 | 0 |
|
| Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages | Vascular pharmacology | | | 2016 | 567 | 0 |
|
| Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury | Journal of Molecular and Cellular Cardiology | | | 2016 | 593 | 1 |
|
| Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis | Thrombosis and haemostasis | | | 2016 | 733 | 1 |
|
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | | | 2016 | 637 | 6 |
|
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | | | 2016 | 774 | 735 |
|
| Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis | Mediators of Inflammation | | | 2016 | 521 | 213 |
|
| Leptin/adiponectin ratio predicts post-stroke neurological outcome | European journal of clinical investigation | | | 2015 | 605 | 1 |
|
| Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | European journal of clinical investigation | | | 2015 | 672 | 0 |
|
| Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways | European heart journal | | | 2015 | 662 | 2 |
|
| Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response | Vascular pharmacology | | | 2015 | 751 | 0 |
|
| Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways | Vascular pharmacology | | | 2015 | 855 | 4 |
|
| Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | | | 2015 | 798 | 0 |
|
| Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice | Vascular pharmacology | | | 2015 | 611 | 0 |
|
| Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | Thrombosis and haemostasis | | | 2015 | 637 | 5 |
|
| Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis | European journal of clinical investigation | | | 2014 | 658 | 0 |
|
| Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice | Thrombosis and haemostasis | | | 2014 | 796 | 0 |
|
| Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice | Thrombosis and haemostasis | | | 2013 | 765 | 0 |
|
| Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice | Journal of cerebral blood flow and metabolism | | | 2013 | 731 | 0 |
|
| Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury | Journal of Molecular and Cellular Cardiology | | | 2013 | 656 | 0 |
|
| Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice | Arteriosclerosis, thrombosis, and vascular biology | | | 2013 | 502 | 1 |
|
| The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques | European heart journal | | | 2012 | 750 | 0 |
|
| Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice | Journal of Molecular and Cellular Cardiology | | | 2010 | 744 | 0 |
|
| CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion | Journal of Molecular and Cellular Cardiology | | | 2009 | 784 | 0 |
|
| HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | AIDS | | | 2009 | 667 | 0 |
|
| Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes | Rheumatology | | | 2009 | 662 | 0 |
|
| Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis | Atherosclerosis | | | 2009 | 639 | 0 |
|
| Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways | Cellular signalling | | | 2008 | 712 | 0 |
|
| C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes | Journal of leukocyte biology | | | 2008 | 656 | 0 |
|
| CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways | American journal of physiology. Heart and circulatory physiology | | | 2008 | 633 | 0 |
|
| A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice | Arteriosclerosis, thrombosis, and vascular biology | | | 2008 | 698 | 0 |
|
| Atorvastatin treatment and vaccination efficacy | Journal of clinical pharmacology | | | 2007 | 615 | 0 |
|
